Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
As of 17 November 2026, for the company name Beijing Sihuan Kebao Pharmaceutical Co., Ltd. as recorded, 8 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 48 records, across 29 drug names; since 21 August 2026, the records list Accepted: 3 applications; the chemical-drug catalogue lists 21 active records with this name as holder; 2 active API registrations list this name as first registered company; 16 further acceptance records name it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.
Drug filings
48 acceptance records as first applicant, grouped into 29 source drug names. Source data as of 2026/11/17.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Cetylpyridinium Chloride Buccal Tablets 1 records · Latest accepted 2026/10/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602521 | Generic | 2026/10/13 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
感冒清解颗粒 · No verified English name 1 records · Latest accepted 2026/09/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2604923 | Supplement | 2026/09/23 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
杏灵分散片 · No verified English name 2 records · Latest accepted 2026/08/24
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2604298 | Supplement | 2026/08/24 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYZB2402144 | Supplement | 2024/11/01 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Fexofenadine Hydrochloride Tablets 4 records · Latest accepted 2026/08/12
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601983 | Generic | 2026/08/12 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2601982 | Generic | 2026/08/12 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2501681 | Generic | 2025/05/09 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2501680 | Generic | 2025/05/09 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
注射用葛根素 · No verified English name 3 records · Latest accepted 2026/06/11
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601100 | Supplement | 2026/06/11 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2601099 | Supplement | 2026/06/11 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2601098 | Supplement | 2026/06/11 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Bosentan Tablets 2 records · Latest accepted 2025/10/10
Supplement · 1Generic · 1
Lornoxicam for Injection 1 records · Latest accepted 2025/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503203 | Generic | 2025/08/30 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2025/04/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501602 | Generic | 2025/04/29 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) 1 records · Latest accepted 2025/04/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501603 | Generic | 2025/04/29 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Fluvastatin Sodium Extended Release Tablets 1 records · Latest accepted 2025/02/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500859 | Generic | 2025/02/27 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Piracetam Injection 2 records · Latest accepted 2025/01/22
Generic · 2
Azithromycin for Suspension 1 records · Latest accepted 2024/09/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403308 | Generic | 2024/09/30 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Ambroxol Hydrochloride Oral Solution 4 records · Latest accepted 2024/09/19
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403121 | Generic | 2024/09/19 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2403120 | Generic | 2024/09/19 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2403119 | Generic | 2024/09/19 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2403118 | Generic | 2024/09/19 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Cetitizine Hydrochloride Oral Solution 2 records · Latest accepted 2024/07/25
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402340 | Generic | 2024/07/25 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2402339 | Generic | 2024/07/25 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
依巴斯汀片 · No verified English name 1 records · Latest accepted 2024/07/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402052 | Generic | 2024/07/06 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
地氯雷他定口服溶液 · No verified English name 3 records · Latest accepted 2024/07/04
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402009 | Generic | 2024/07/04 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2402008 | Generic | 2024/07/04 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2402007 | Generic | 2024/07/04 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Nicorandil Tablets 1 records · Latest accepted 2024/03/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400774 | Generic | 2024/03/06 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Bilastine Tablets 1 records · Latest accepted 2024/02/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400460 | Generic | 2024/02/03 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Nicorandil for Injection 3 records · Latest accepted 2023/09/06
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301996 | Supplement | 2023/09/06 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2250167 | Supplement | 2022/03/17 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2250166 | Supplement | 2022/03/17 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Pentoxifylline Injection 1 records · Latest accepted 2023/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302319 | Generic | 2023/08/30 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Felodipine Sustained Release Tablets 2 records · Latest accepted 2023/08/22
Supplement · 2
Mitiglinide Calcium Tablets 2 records · Latest accepted 2023/05/23
Supplement · 2
Omeprazole Sodium for Injection 1 records · Latest accepted 2023/01/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350072 | Supplement | 2023/01/17 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
注射用尼莫地平 · No verified English name 2 records · Latest accepted 2022/08/23
Supplement · 2
Rupatadine Fumarate Tablets 1 records · Latest accepted 2022/08/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250471 | Supplement | 2022/08/01 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
二甲双胍格列吡嗪片 · No verified English name 1 records · Latest accepted 2022/05/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250283 | Supplement | 2022/05/24 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Olopatadine Hydrochloride Tablets 1 records · Latest accepted 2022/04/19
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200643 | Supplement | 2022/04/19 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Olopatadine Hydrochloride Granules 1 records · Latest accepted 2021/12/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102147 | Generic | 2021/12/06 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
二甲双胍格列吡嗪片(II) · No verified English name 1 records · Latest accepted 2021/09/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150894 | Supplement | 2021/09/29 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
3 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 3 applications
- 2026/10/13Accepted
Cetylpyridinium Chloride Buccal Tablets
CYHS2602521
Fact date: 2026/10/13 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/23Accepted
感冒清解颗粒 · No verified English name
CYZB2604923
Fact date: 2026/09/23 · Date added to this site: 2026/10/22
View source ↗ - 2026/08/24Accepted
杏灵分散片 · No verified English name
CYZB2604298
Fact date: 2026/08/24 · Date added to this site: 2026/10/22
View source ↗
Under review
8 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Cetylpyridinium Chloride Buccal Tablets | CYHS2602521 | Generic | 2026/10/13 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| 感冒清解颗粒 · No verified English name | CYZB2604923 | Supplement | 2026/09/23 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| 杏灵分散片 · No verified English name | CYZB2604298 | Supplement | 2026/08/24 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Fexofenadine Hydrochloride Tablets | CYHS2601983 | Generic | 2026/08/12 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Fexofenadine Hydrochloride Tablets | CYHS2601982 | Generic | 2026/08/12 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Lornoxicam for Injection | CYHS2503203 | Generic | 2025/08/30 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) | CYHS2501603 | Generic | 2025/04/29 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) | CYHS2501602 | Generic | 2025/04/29 | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
21 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Piracetam Injection | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20265604 | 2026/08/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluvastatin Sodium Extended Release Tablets | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20265424 | 2026/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin for Suspension | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20263438 | 2026/02/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bosentan Tablets | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20269002 | 2026/01/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pentoxifylline Injection | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20263047 | 2026/01/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Piracetam Injection | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20263020 | 2026/01/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 依巴斯汀片 · No verified English name | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20256147 | 2025/12/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Omeprazole Sodium for Injection | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20059318 | 2025/09/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nicorandil Tablets | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20254812 | 2025/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nicorandil for Injection | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20247283 | 2024/11/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bosentan Tablets | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20249140 | 2024/10/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mitiglinide Calcium Tablets | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20153166 | 2024/05/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Mitiglinide Calcium Tablets | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20247007 | 2024/01/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olopatadine Hydrochloride Granules | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20234298 | 2023/10/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rupatadine Fumarate Tablets | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20140097 | 2023/09/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nicorandil for Injection | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20120069 | 2023/07/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nicorandil for Injection | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20120070 | 2023/07/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 二甲双胍格列吡嗪片 · No verified English name | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20140028 | 2023/05/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olopatadine Hydrochloride Tablets | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20237031 | 2023/03/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 二甲双胍格列吡嗪片(II) · No verified English name | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20140029 | 2022/10/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Felodipine Sustained Release Tablets | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | 国药准字H20223110 | 2022/03/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
2 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 盐酸贝凡洛尔 · No verified English name | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Y20190008863 | A | 2023/03/24 | CDE ↗ |
| 硫辛酸 · No verified English name | Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | Y20190004123 | A | 2023/03/24 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
16 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Indobufen Tablets | CYHB2600780 | Supplement | 2026/04/18 | Beijing Jia Lin Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| 二甲双胍格列吡嗪片 · No verified English name | CYHB2501345 | Supplement | 2025/07/09 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| 二甲双胍格列吡嗪片(II) · No verified English name | CYHB2302808 | Supplement | 2023/12/30 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| 二甲双胍格列吡嗪片 · No verified English name | CYHB2302807 | Supplement | 2023/12/30 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用硝酸异山梨酯 · No verified English name | CYHB2302770 | Supplement | 2023/12/26 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用硝酸异山梨酯 · No verified English name | CYHB2302769 | Supplement | 2023/12/26 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用硝酸异山梨酯 · No verified English name | CYHB2302768 | Supplement | 2023/12/26 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Atorvastatin Calcium Tablets | CYHB2302311 | Supplement | 2023/10/18 | Beijing Wei Lin Heng Chang Pharmaceuticals Technology Co., Ltd. romanized; Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Atorvastatin Calcium Tablets | CYHB2302310 | Supplement | 2023/10/18 | Beijing Wei Lin Heng Chang Pharmaceuticals Technology Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd.; Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | CDE ↗ |
| Indobufen Tablets | CYHS2302426 | Generic | 2023/09/09 | Beijing Wei Lin Heng Chang Pharmaceuticals Technology Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Ozagrel Sodium Injection | CYHS2300985 | Generic | 2023/04/06 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Ozagrel Sodium Injection | CYHS2300984 | Generic | 2023/04/06 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Citicoline Sodium Injection | CYHS2300904 | Generic | 2023/03/27 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Citicoline Sodium Injection | CYHS2300903 | Generic | 2023/03/27 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Granisetron Hydrochloride injection | CYHS2300812 | Generic | 2023/03/17 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
| Cetirizine Hydrochloride Injection | CYHS2201895 | Generic | 2022/11/05 | Beijing Si Huan Ke Bao Pharma Co., Ltd. romanized; Beijing Sihuan Kebao Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/17
- Chemical-drug catalogue
- Last successful update: 2026/11/17
- API registrations
- Last successful update: 2026/11/17
- NMPA drug delivery notices
- Last successful update: 2026/11/17
Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.